These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11220871)

  • 1. [Role of grandaxin in the treatment of functional gastrointestinal diseases].
    Osipenko MF; Khramov IuA; Makarova TA; Vdovenko EG
    Ter Arkh; 2000; 72(10):23-7. PubMed ID: 11220871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of grandaxin in hypermotor dysfunction of the biliary ducts in young people].
    Plotnikova EIu; Beloborodova EI
    Eksp Klin Gastroenterol; 2005; (6):65-70, 113-4. PubMed ID: 17378391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of grandaxin in the treatment of somatoform disorders].
    Veĭn AV; Artemenko AR; Oknin VIu; Pomortseva IV
    Klin Med (Mosk); 1999; 77(6):41-5. PubMed ID: 10459219
    [No Abstract]   [Full Text] [Related]  

  • 4. [Structure of the anxious-delusional syndrome of schizophrenic patients during treatment with anxiolytics].
    Vasil'ev AA; Nuller IuL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(8):1217-22. PubMed ID: 2877531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autonomic effect of grandaxin in the treatment of neurotic disorders in general somatic practice (lecture)].
    Aleksandrovskiĭ IuA; Avedisova AS; Pavlova MS
    Ter Arkh; 1998; 70(10):76-8. PubMed ID: 9864811
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of emotional disorders, anxiety and depression, in patients with gastrointestinal disease.
    Kasich AM
    Curr Ther Res Clin Exp; 1965 Sep; 7(9):542-7. PubMed ID: 4953854
    [No Abstract]   [Full Text] [Related]  

  • 7. Preliminary report on antidepressant treatment of irritable bowel syndrome: comments on comparison with anxiolytic therapy.
    Greenbaum DS
    Psychopharmacol Bull; 1984; 20(4):622-8. PubMed ID: 6149598
    [No Abstract]   [Full Text] [Related]  

  • 8. [The course of coronary heart disease and quality of life in patients with anxiety of different degree].
    Ibatov AD
    Ter Arkh; 2007; 79(12):35-8. PubMed ID: 18220028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Action of the bromazepam-propantheline combination in patients with organic and functional gastrointestinal disorders].
    Laghi-Pasini F
    Clin Ter; 1977 Nov; 83(3):301-11. PubMed ID: 23917
    [No Abstract]   [Full Text] [Related]  

  • 10. [Trial of a new psychotropical agent in digestive pathology: the fenpentadiol].
    Alary R; Chapuy H; Dietsch R; Savoye B
    J Med Lyon; 1971 Jun; 52(210):951-5. PubMed ID: 5132690
    [No Abstract]   [Full Text] [Related]  

  • 11. [Psychophysiologic disorders in patients with functional disorders of upper sections of the gastrointestinal tract and with gastroesophageal reflux disease].
    Rykova SM; Pogromov AP; Diukova GM; Veĭn AM
    Eksp Klin Gastroenterol; 2003; (4):21-6, 113. PubMed ID: 14653230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting.
    Addolorato G; Mirijello A; D'Angelo C; Leggio L; Ferrulli A; Abenavoli L; Vonghia L; Cardone S; Leso V; Cossari A; Capristo E; Gasbarrini G
    Int J Clin Pract; 2008 Jul; 62(7):1063-9. PubMed ID: 18422970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition and treatment of depression and anxiety in patients with acute myocardial infarction.
    Huffman JC; Smith FA; Blais MA; Beiser ME; Januzzi JL; Fricchione GL
    Am J Cardiol; 2006 Aug; 98(3):319-24. PubMed ID: 16860016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of depression and anxiety following myocardial infarction.
    Stern TA
    Mt Sinai J Med; 1985 Oct; 52(8):623-33. PubMed ID: 2867465
    [No Abstract]   [Full Text] [Related]  

  • 15. [Excerpts from the clinical-pharmacologic and clinical studies of Grandaxin].
    Szegó J; Somogyi M; Papp E
    Acta Pharm Hung; 1993 Mar; 63(2):91-8. PubMed ID: 8100114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations with tofisopam (grandaxin) treatment in children's diseases.
    Szórády I; Borsodi A
    Ther Hung; 1983; 31(4):172-5. PubMed ID: 6152818
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacologic correction of psycho-emotive disorders in the rehabilitation of patients after removal of brain tumors].
    Koval'chuk VV
    Vopr Onkol; 2007; 53(6):704-10. PubMed ID: 18416142
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of grandaxine in the treatment of patients with erosive-ulcerative stomach and gastroduodenal lesions].
    Vakhrushev IaM; Belova EV; Efremova LI
    Eksp Klin Gastroenterol; 2004; (4):21-4. PubMed ID: 15568662
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division.
    Pasquini M; Biondi M; Costantini A; Cairoli F; Ferrarese G; Picardi A; Sternberg C
    Depress Anxiety; 2006; 23(7):441-8. PubMed ID: 16841345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Irritable bowel syndrome(IBS)].
    Kawasaki Y; Fujita K
    Ryoikibetsu Shokogun Shirizu; 2003; (38):559-62. PubMed ID: 12877049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.